Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Mylan launches generic EpiPen as its sued by 20 states over generics price-fixing

Mylan announced the launch of the authorized generic of its allergic reaction autoinjector treatment, EpiPen. Although the launch fulfilled a promise the pharmaceutical company made months ago, it came only hours after 20 states filed a lawsuit over Mylan’s pricing of other generic drugs. 

ACA replacement—just not repeal—may find Democratic support

Repealing the Affordable Care Act (ACA) can be passed with only Republican votes soon after President-elect Donald Trump takes office. Replacing the law, however, can’t be done by one party.

White House report defends ACA as ‘historic progress’

A report on the “economic record” of the Obama Administration’s healthcare reforms credited the Affordable Care Act (ACA) for lower uninsured rates, increased access to care and slowed growth in healthcare spending.

HHS Secretary: Healthcare reform must ‘continue to endure’

HHS Secretary Sylvia Burwell defended the Affordable Care Act (ACA) and the broader efforts of changing healthcare payments, delivery systems and health IT in a Health Affairs blog post.

Aura Labs settles with FTC for inaccurate blood pressure app

Aura Labs has agreed to settle charges from the Federal Trade Commission (FTC) relating to its Instant Blood Pressure (IBP) mobile application, which came under fire for claims that is was as effective as a conventional blood pressure cuff.

52 million with pre-existing conditions could be denied coverage if ACA repealed

If pre-Affordable Care Act (ACA) health insurance regulations returned with a repeal of the law, 52 million people under the age of 65—27 percent of the U.S. population—could be denied coverage on the individual market due to pre-existing conditions.

Physicians likely to have an ally in Tom Price at HHS

The nominee to run HHS under President-elect Donald Trump has a history of putting doctors’ interests first.

‘Dramatic slowdown’ in value-based care transition—and how Congress can jumpstart it

Members of the American Medical Group Association (AMGA) reported the transition to value-based care is slower than expected, with more multispecialty medical groups and integrated systems predicting fee-for-service (FFS) payments will take up a greater percentage of revenues in the next few years than originally projected.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.